6 unknown. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
| Phase 1 | 2 | Unknown 2 |
Follow Sarcoma, Synovial: new trials by email Literature Review of Sarcoma, Synovial trials Research Report on Sarcoma, Synovial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas Hypofractionated radiotherapy, Hyperthermia - Sarcoma, Alveolar Soft Part Sarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 30 | 2018-06-01 | 2021-02-01 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies CAR-T cell immunotherapy - B-cell Acute Lymphoblastic Leukemia, Lymphoma | Phase 1 / Phase 2 | Unknown | Shenzhen BinDeBio Ltd. | 73 | 2018-03-01 | 2019-12-11 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Sequential chemotherapy - 3 courses of AI, Hypofractionated radiotherapy - Sarcoma, Fibrosarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 46 | 2017-02-11 | 2021-01-22 |
| Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma Autologous dendritic cell vaccine - Sarcoma, Neoplasms, Connective and Soft Tissue | Phase 1 / Phase 2 | Unknown | N.N. Petrov National Medical Research Center of Oncology | 48 | 2013-06-01 | 2019-11-20 |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma brostallicin, doxorubicin hydrochloride - Ovarian Cancer, Sarcoma | Phase 2 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 118 | 2006-10-01 | 2014-08-08 |
| Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma temozolomide - Endometrial Cancer, Ovarian Cancer | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 25 | 1998-09-01 | 2014-01-06 |
Fibrosarcoma (5) · Histiocytoma, Malignant Fibrous (5) · Leiomyosarcoma (5) · Liposarcoma (5) · Neurofibrosarcoma (5) · Sarcoma (5) · Sarcoma, Alveolar Soft Part (4) · Ovarian Neoplasms (3) · Rhabdomyosarcoma (3) · Hemangiosarcoma (2) · Liposarcoma, Myxoid (2) · Malignant mesenchymal tumor (2) · Myosarcoma (2) · Burkitt Lymphoma (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Connective Tissue (6) · Neoplasms, Nerve Tissue (6) · Neoplasms, Adipose Tissue (5) · Neoplasms, Connective and Soft Tissue (5) · Neoplasms, Fibrous Tissue (5) · Neoplasms, Muscle Tissue (5) · Nerve Sheath Neoplasms (5) · Nervous System Diseases (5) · Nervous System Neoplasms (5) · Neurofibroma (5) · Neuromuscular Diseases (5) · Peripheral Nervous System Diseases (5) · Peripheral Nervous System Neoplasms (5)
Radiation Dose Hypofractionation (2) · Diathermy (1) · Doxorubicin (1) · Immunotherapy, Adoptive (1) · Temozolomide (1) · brostallicin (1) · lentiviral minigene vaccine of COVID-19 coronavirus (1)
Maria Sklodowska-Curie National Research Institute of Oncology (2) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Herbert Irving Comprehensive Cancer Center (1) · N.N. Petrov National Medical Research Center of Oncology (1) · Shenzhen BinDeBio Ltd. (1)
Poland (2) · China (1) · Netherlands (1) · Russia (1) · United States (1)
Hans Gelderblom, MD, PhD (1) · Robert N. Taub, MD, PhD (1) · Yuriy Komarov, PhD (1)